My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2020/690 of 17 December 2019 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the listed diseases subject to Union surveillance programmes, the geographical scope of such programmes and the listed diseases for which the disease-free status of compartments may be established (Text with EEA relevance) (Text with EEA relevance)

Commission Implementing Regulation (EU) 2020/690 of 17 December 2019 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the listed diseases subject to Union surveillance programmes, the geographical scope of such programmes and the listed diseases for which the disease-free status of compartments may be established (Text with EEA relevance) (Text with EEA relevance)

Implementing Regulation (EU) 2020/690 · Regulation · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The listed diseases subject to Union surveillance programmes in accordance with Article 28 of Regulation (EU) 2016/429 and the geographical scope of such programmes are set out in Annex I to this Regulation.

Article 2

Open ↗

The listed diseases for which the disease-free status of compartments may be established in accordance with Article 37 of Regulation (EU) 2016/429 are set out in Annex II to this Regulation.

Article 3

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 21 April 2021.

Supplementary provisions

ANNEX ISupplementary provisions

Open ↗

ANNEX I LISTED DISEASES SUBJECT TO UNION SURVEILLANCE PROGRAMMES GEOGRAPHICAL SCOPE OF UNION SURVEILLANCE PROGRAMMES Highly pathogenic avian influenza Entire territory of Member State Infection with low pathogenic avian influenza viruses Entire territory of Member State

ANNEX IISupplementary provisions

Open ↗

ANNEX II LISTED DISEASES FOR WHICH THE DISEASE-FREE STATUS OF COMPARTMENTS MAY BE ESTABLISHED Epizootic haematopoietic necrosis Viral haemorrhagic septicaemia Infectious haematopoietic necrosis Infection with highly polymorphic region (HPR) deleted infectious salmon anaemia virus Infection with Microcytos mackini Infection with Perkinsus marinus Infection with Bonamia ostreae Infection with Bonamia exitiosa Infection with Marteilia refringens Infection with Taura syndrome virus Infection with yellow head virus Infection with white spot syndrome virus

Other acts of the same type
Commission Regulation (EU) 2021/1297 of 4 August 2021 amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council as regards perfluorocarboxylic acids containing 9 to 14 carbon atoms in the chain (C9-C14 PFCAs), their salts and C9-C14 PFCA-related substances (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/1293 of 3 August 2021 amending Implementing Regulation (EU) 2021/823 imposing a definitive countervailing duty on imports of certain rainbow trout originating in Turkey following an expiry review pursuant to Article 18 of Regulation (EU) 2016/1037 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2021/1322 of 3 August 2021 amending Implementing Regulation (EU) 2019/2076 to make administrative changes to the Union authorisation of the biocidal product family ‘Contec IPA Product Family’ (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/1280 of 2 August 2021 as regards measures on good distribution practice for active substances used as starting materials in veterinary medicinal products in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/1281 of 2 August 2021 laying down rules for the application of Regulation (EU) 2019/6 of the European Parliament and of the Council as regards good pharmacovigilance practice and on the format, content and summary of the pharmacovigilance system master file for veterinary medicinal products (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/1309 of 2 August 2021 entering a name in the register of protected designations of origin and protected geographical indications [‘Värmländskt skrädmjöl’ (PGI)]Council Regulation (EU) 2021/1275 of 30 July 2021 concerning restrictive measures in view of the situation in LebanonCouncil Implementing Regulation (EU) 2021/1276 of 30 July 2021 implementing Regulation (EU) 2019/1716 concerning restrictive measures in view of the situation in NicaraguaCommission Delegated Regulation (EU) 2021/1934 of 30 July 2021 amending Delegated Regulation (EU) 2015/2446 as regards certain provisions relating to the origin of goodsCouncil Implementing Regulation (EU) 2021/1241 of 29 July 2021 implementing Article 21(2) of Regulation (EU) 2016/44 concerning restrictive measures in view of the situation in Libya and repealing Regulation (EU) No 204/2011Council Implementing Regulation (EU) 2021/1242 of 29 July 2021 implementing Regulation (EU) No 267/2012 concerning restrictive measures against IranCommission Regulation (EU) 2021/1247 of 29 July 2021 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for mandestrobin in grapes and strawberries (Text with EEA relevance)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next